Table I.
Study | Country | Total number of cases | Age group (yr) | Number of cases (%) | Deaths (%) | Case-fatality rate (%) |
---|---|---|---|---|---|---|
The Novel | China | 72,314 | 0-9 | 416 (0.9) | - | - |
Coronavirus Pneumonia | (confirmed cases - | |||||
Emergency Response | 44,672) | 10-19 | 549 (1.2) | 1 (0.1) | 0.2 | |
Epidemiology Team3 | 20-29 | 3619 (8.1) | 7 (0.7) | 0.2 | ||
30-39 | 7600 (17.0) | 18 (1.8) | 0.2 | |||
40-49 | 8571 (19.2) | 38 (3.7) | 0.4 | |||
50-59 | 10,008 (22.4) | 130 (12.7) | 1.3 | |||
60-69 | 8583 (19.2) | 312 (30.5) | 3.6 | |||
70-79 | 3918 (8.8) | 309 (30.2) | 8.0 | |||
≥80 | 1408 (3.2) | 208 (20.3) | 14.8 | |||
Total | 44,672 | 1023 | 2.3 | |||
Livingston and Bucher, 20204 | Italy | 22,512 | 0-9 | Number of cases not available in the range taken for comparison (age group mentioned as 0-18, 19-50, 51-70 and >70 yr) | 0 | 0 |
10-19 | 0 | 0 | ||||
20-29 | 0 | 0 | ||||
30-39 | 4 (0.2) | 0.3 | ||||
40-49 | 10 (0.6) | 0.4 | ||||
50-59 | 43 (2.6) | 1.0 | ||||
60-69 | 139 (8.5) | 3.5 | ||||
70-79 | 578 (35.6) | 12.5 | ||||
80-89 | 694 (42.7) | 19.7 | ||||
≥90 | 156 (9.6) | 22.7 | ||||
Not reported | 1 (0.06) | 0.6 | ||||
Total | 22,512 | 1625 (100) | 7.2 | |||
CDC COVID-19 Response Team, USA5 | USA | 4,226 (confirmed cases - 2,449) | 0-19 | 123 (5) | 0 | 0 |
20-44 | 705 (29) | 9 (20) | 0.1-0.2* | |||
45-54 | 429 (18) | 0.5-0.8 | ||||
55-64 | 429 (18) | 1.4-2.6 | ||||
65-74 | 409 (17) | 20 (46) | 2.7-4.9 | |||
75-84 | 210 (9) | 4.3-10.5 | ||||
≥85 | 144 (6) | 15 (34) | 10.4-27.3 | |||
Total | 2449 | 44 | 1.8-3.4 | |||
Korean Society of Infectious | South Korea | 4,212 | 0-9 | 32 (1) | 0 | 0 |
Diseases6 | 10-19 | 169 (4) | 0 | 0 | ||
20-29 | 1235 (30) | 0 | 0 | |||
30-39 | 506 (12) | 1 (4.5) | 0.2 | |||
40-49 | 633 (15) | 1 (4.5) | 0.2 | |||
50-59 | 834 (20) | 5 (22.7) | 0.6 | |||
60-69 | 530 (12) | 6 (27.3) | 1.1 | |||
70-79 | 192 (5) | 6 (27.3) | 3.1 | |||
≥80 | 81 (2) | 3 (13.6) | 3.7 | |||
Total | 4,212 | 22 | 0.5 |
*In lower and upper bound ranges